(1)連結損益計算書及び連結包括利益計算書

連結損益計算書

(単位:百万円)

 

 

前連結会計年度

(自 2022年4月1日

至 2023年3月31日)

当連結会計年度

(自 2023年4月1日

至 2024年3月31日)

売上収益

 

555,544

314,558

売上原価

 

178,919

126,577

売上総利益

 

376,625

187,981

販売費及び一般管理費

 

373,316

429,538

研究開発費

 

131,858

112,637

その他の収益

 

53,256

7,467

その他の費用

 

1,686

8,132

営業利益(△は損失)

 

76,979

354,859

金融収益

 

32,218

36,022

金融費用

 

3,159

4,277

税引前当期利益(△は損失)

 

47,920

323,114

法人所得税

 

48,794

8,185

当期利益(△は損失)

 

96,714

314,929

当期利益(△は損失)の帰属

 

 

 

親会社の所有者持分

 

74,512

314,969

非支配持分

 

22,202

40

当期利益(△は損失)

 

96,714

314,929

1株当たり当期利益(円)

 

 

 

基本的1株当たり当期利益(△は損失)

 

187.55

792.79

 

 

E00922 45060 住友ファーマ株式会社 Sumitomo Pharma Co., Ltd. 通期第3号様式 [IFRS](連結) IFRS true cte cte 2023-04-01 2024-03-31 FY 2024-03-31 2022-04-01 2023-03-31 2023-03-31 1 false false false 45060 2024-05-14 45060 2023-04-01 2024-03-31 45060 2023-04-01 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45060 2023-04-01 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45060 2023-04-01 2024-03-31 tse-acediffr-45060:OtherComprehensiveIncomeAssociatedWithAssetsHeldForSaleIFRSMember 45060 2024-03-31 45060 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45060 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45060 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45060 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45060 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45060 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45060 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45060 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45060 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45060 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45060 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45060 2024-03-31 tse-acediffr-45060:OtherComprehensiveIncomeAssociatedWithAssetsHeldForSaleIFRSMember 45060 2022-04-01 2023-03-31 45060 2022-04-01 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 45060 2022-04-01 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 45060 2022-04-01 2023-03-31 tse-acediffr-45060:OtherComprehensiveIncomeAssociatedWithAssetsHeldForSaleIFRSMember 45060 2023-03-31 45060 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 45060 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45060 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45060 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45060 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45060 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45060 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45060 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45060 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 45060 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 45060 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 45060 2023-03-31 tse-acediffr-45060:OtherComprehensiveIncomeAssociatedWithAssetsHeldForSaleIFRSMember 45060 2022-03-31 45060 2022-03-31 jpigp_cor:CapitalSurplusIFRSMember 45060 2022-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45060 2022-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45060 2022-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45060 2022-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45060 2022-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45060 2022-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45060 2022-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45060 2022-03-31 jpigp_cor:RetainedEarningsIFRSMember 45060 2022-03-31 jpigp_cor:ShareCapitalIFRSMember 45060 2022-03-31 jpigp_cor:TreasurySharesIFRSMember 45060 2022-03-31 tse-acediffr-45060:OtherComprehensiveIncomeAssociatedWithAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure